Skip to main content
. 2023 Oct 5;19(1):1–9. doi: 10.1159/000533657

Table 1.

Patient characteristics at diagnosis in the main analysis set

Characteristic N = 187
Median age, years (range)a 53.0 (22.0–81.0)
Ethnic group, n (%)
 Black 1 (0.5)
 Caucasian 177 (94.7)
 Other 9 (4.8)
Median (IQR) BMI, kg/m2 26.0 (22.8–29.8)
Menopausal status (primary diagnosis), n (%)
 Premenopausal 82 (43.9)
 Perimenopausal 14 (7.5)
 Postmenopausal 91 (48.7)
Employment status, n (%)
 Employed full-time 56 (29.9)
 Employed part-time 47 (25.1)
 Unemployed, not disease related 12 (6.4)
 Unemployed, disease related 26 (13.9)
 Retired 39 (20.9)
 Missing 7 (3.7)
ECOG performance status, n (%)
 0 133 (71.1)
 1 47 (25.1)
 2 3 (1.6)
 Not evaluated 4 (2.1)
Clinical T-stage at primary diagnosis, n (%)
 cT0/cTis (DCIS) 1 (0.5)/2 (1.1)
 cT1 23 (12.3)
 cT1a/cT1b 2 (1.1)/12 (6.4)
 cT1c 55 (29.4)
 cT2 73 (39.0)
 cT3 8 (4.3)
 cT4/cT4d 1 (0.5)/1 (0.5)
 cTX 9 (4.8)
Clinical N-stage at primary diagnosis, n (%)
 cN0/cN1mi 116 (62.0)/3 (1.6)
 cN1 48 (25.7)
 cN2 4 (2.1)
 cN2a/b 1 (0.5)/1 (0.5)
 cN3 1 (0.5)
 cN3a 1 (0.5)
 cNX 12 (6.4)
AJCC stage at primary diagnosis, n (%)
 TisN0M0 1 (0.5)
 IA 69 (36.9)
 IIA 55 (29.4)
 IIB 26 (13.9)
 IIIA 10 (5.3)
 IIIB 2 (1.1)
 IIIC 2 (1.1)
 MX 11 (5.9)
 TX/NX 11 (5.9)
WHO tumor grading at primary diagnosis, n (%)
 G1 3 (1.6)
 G2 82 (43.9)
 G3 92 (49.2)
 GX 10 (5.3)
Ki67 status,bn (%)
 High 120 (64.2)
 Low 54 (28.9)
 Unknown 13 (7.0)

AJCC, American Joint Committee on Cancer; BMI, body mass index; c, clinical; DCIS, ductal carcinoma in situ; ECOG, Eastern Cooperative Oncology Group; G, grading; IQR, interquartile range; mi, micro-metastasis; M, metastasis; N, lymph node; T, tumor; WHO, World Health Organization; X, status not determined.

aAt date of informed consent.

bAs per center standard definition.